Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
156 hedge funds and large institutions have $137M invested in Immunogen Inc in 2016 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 41 reducing their positions, and 25 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 41
8% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 25
1% more funds holding
Funds holding: 155 → 156 (+1)
32% less capital invested
Capital invested by funds: $201M → $137M (-$64.3M)
52% less call options, than puts
Call options by funds: $459K | Put options by funds: $948K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.56M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.04M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$818K |
| 4 |
Millennium Management
New York
|
+$811K |
| 5 |
D.E. Shaw & Co
New York
|
+$809K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$9.17M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.64M |
| 3 |
ClearBridge Investments
New York
|
-$3.27M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.79M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$2.54M |
IMGN Hedge Fund Activity: Q4 2016 in Review
156 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2016, worth a combined $137M — down 32% from $201M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new IMGN positions and 25 closed out — a net gain of 2 holders — while 50 added to existing stakes and 41 trimmed.
The largest buyer was Schonfeld Strategic Advisors, opening a new position worth an estimated $1.56M. The largest seller was Primecap Management, cutting an estimated $9.17M.
- 156 institutional investors held Immunogen Inc (IMGN) as of Q4 2016, up from 155 in Q3 2016.
- Funds reported $137M of Immunogen Inc stock for Q4 2016, down 32% quarter-over-quarter.
- 27 funds opened new Immunogen Inc positions in Q4 2016 and 25 closed out, a net change of +2 holders.
- The largest Immunogen Inc buyer in Q4 2016 was Schonfeld Strategic Advisors, an estimated $1.56M added.
- The largest Immunogen Inc seller in Q4 2016 was Primecap Management, an estimated $9.17M sold.
Based on aggregated 13F filings for Q4 2016.